Polar Asset Management Partners’s AbCellera Biologics ABCL Stock Holding History

Polar Asset Management Partners’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-159,800	Closed	-$548K	–	660
2025 Q2	$548K	Buy	+159,800	New	+$398K	0.01%	405
2025 Q1	–	Sell	-117,830	Closed	-$345K	–	531
2024 Q4	$345K	Hold	117,830	–	–	﹤0.01%	481
2024 Q3	$306K	Hold	117,830	–	–	0.01%	477
2024 Q2	$349K	Hold	117,830	–	–	0.01%	441
2024 Q1	$534K	Hold	117,830	–	–	0.01%	462
2023 Q4	$673K	Hold	117,830	–	–	0.01%	450
2023 Q3	$542K	Hold	117,830	–	–	0.01%	492
2023 Q2	$761K	Hold	117,830	–	–	0.01%	536
2023 Q1	$888K	Hold	117,830	–	–	0.01%	589
2022 Q4	$1.19M	Hold	117,830	–	–	0.01%	672
2022 Q3	$1.17M	Hold	117,830	–	–	0.01%	752
2022 Q2	$1.25M	Sell	117,830 -510,300	-81%	-$4.32M	0.01%	737
2022 Q1	$6.12M	Buy	+628,130	New	+$5.95M	0.07%	357
2021 Q4	–	Sell	-25,000	Closed	-$501K	–	1296
2021 Q3	$501K	Sell	25,000 -30,000	-55%	-$530K	﹤0.01%	840
2021 Q2	$1.21M	Buy	55,000 +15,000	+38%	+$414K	0.01%	604
2021 Q1	$1.36M	Sell	40,000 -135,000	-77%	-$5.38M	0.01%	522
2020 Q4	$7.04M	Buy	+175,000	New	+$8M	0.08%	241

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Polar Asset Management Partners's ABCL Position: Q3 2025 in Review

Polar Asset Management Partners sold out of AbCellera Biologics (ABCL) in Q3 2025, closing a stake of 159,800 shares — an estimated $548K sold.

Polar Asset Management Partners first reported a position in ABCL in Q4 2020 and held it in 17 quarters. The position peaked at $7.04M in Q4 2020. 141 funds tracked by Wall St. Rank hold ABCL as of Q3 2025.

Polar Asset Management Partners reported no remaining AbCellera Biologics position as of Q3 2025 after selling out during the quarter.
Polar Asset Management Partners sold 159,800 AbCellera Biologics shares in Q3 2025, an estimated $548K.
Polar Asset Management Partners first reported a position in AbCellera Biologics in Q4 2020 and held it in 17 quarters.
Polar Asset Management Partners's AbCellera Biologics position peaked at $7.04M in Q4 2020.
141 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2025.

Based on Polar Asset Management Partners's 13F filing for Q3 2025, filed 14 Nov 2025.